Compound Detail
CHEMBL415
CLOMIPRAMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL415 |
| Name | CLOMIPRAMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | GDLIGKIOYRNHDA-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
53
Targets
116
Activities
4
Assay Types
22
PK Parameters
20
Publications
7
Known Names
7
Indications
Molecular Properties
314.9
MW (Da)
4.53
ALogP
2
HBA
0
HBD
6.5
PSA (Ų)
0.82
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1989 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Depressive Disorder Depressive Disorder Anxiety Dementia Obsessive-Compulsive Disorder Premature Ejaculation Schizophrenia
ATC Classification
N06AA04
clomipramine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 69 meas. best 10.4
Ki 44 meas. best 10.33
EC50 2 meas. best 5.3
Kd 1 meas.
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 10.4 | 8.7 | 0.0 | 2 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 10.33 | 9.94 | 0.0 | 2 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 10.06 | 8.61 | 0.1 | 2 |
| Histamine H1 receptor CHEMBL4701 | IC50 | 9.7 | 9.7 | 0.2 | 1 |
| Serotonin (5-HT) receptor CHEMBL2094123 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 8.08 | 8.08 | 8.3 | 1 |
| Histamine H1 receptor CHEMBL231 | Ki | 8.01 | 8.01 | 9.8 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 7.89 | 7.89 | 13.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 7.75 | 7.75 | 18.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 7.72 | 7.72 | 19.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL313 | IC50 | 7.7 | 7.375 | 20.0 | 2 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 7.66 | 7.66 | 22.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 7.47 | 7.47 | 34.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 7.44 | 7.44 | 36.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | Ki | 7.42 | 7.42 | 38.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 7.4 | 7.4 | 40.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 7.37 | 5.8963 | 43.0 | 8 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 7.34 | 7.34 | 46.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.34 | 5.8133 | 46.0 | 9 |
| D(3) dopamine receptor CHEMBL234 | Ki | 7.33 | 7.33 | 47.0 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | Ki | 7.29 | 7.29 | 51.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | IC50 | 7.28 | 7.28 | 53.0 | 1 |
| D(2) dopamine receptor CHEMBL339 | Ki | 7.25 | 7.25 | 56.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 7.19 | 7.17 | 64.6 | 2 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 7.17 | 7.17 | 67.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 7.16 | 7.16 | 70.0 | 1 |
| Sodium-dependent serotonin transporter CHEMBL4642 | IC50 | 7.16 | 7.16 | 70.0 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | Ki | 7.14 | 7.14 | 73.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 7.12 | 7.12 | 75.0 | 1 |
| Histamine H1 receptor CHEMBL231 | IC50 | 7.07 | 7.07 | 85.0 | 1 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | Ki | 7.07 | 7.07 | 86.0 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 7.06 | 7.06 | 88.0 | 1 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | IC50 | 7.04 | 7.04 | 91.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | IC50 | 7.04 | 7.04 | 91.0 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 7.0 | 7.0 | 101.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 6.95 | 6.945 | 112.0 | 2 |
| Alpha-1B adrenergic receptor CHEMBL315 | IC50 | 6.88 | 6.88 | 132.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 6.86 | 6.86 | 139.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 6.86 | 6.86 | 138.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 6.82 | 6.82 | 152.0 | 1 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | IC50 | 6.77 | 6.77 | 170.0 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | IC50 | 6.75 | 6.75 | 180.0 | 1 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 6.69 | 6.69 | 205.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 6.62 | 6.62 | 239.0 | 1 |
| Muscarinic acetylcholine receptor M2 CHEMBL211 | IC50 | 6.62 | 6.62 | 241.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | IC50 | 6.61 | 6.61 | 245.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 6.38 | 6.38 | 413.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL1867 | Ki | 6.28 | 6.28 | 530.0 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 6.25 | 6.25 | 557.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 6.24 | 6.24 | 572.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 8.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1047.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 134.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 122.5 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 10.9 | mL.min-1.kg-1 | Homo sapiens |
| F | 79.0 | % | Homo sapiens |
| Fu | 0.04 | - | Homo sapiens |
| Fu | 0.029 | - | Homo sapiens |
| Fu | 0.19 | - | Homo sapiens |
| Fu | 0.004 | - | Homo sapiens |
| Fu | 0.006 | - | Macaca fascicularis |
| Fu | 0.004 | - | Canis lupus familiaris |
| Fu | 0.003 | - | Cavia porcellus |
| Fu | 0.004 | - | Mus musculus |
| Fu | 0.003 | - | Rattus norvegicus |
| Fu | 0.004 | - | Rattus norvegicus |
| Fu | 0.022 | - | Not specified |
| Fu | 0.186 | - | Homo sapiens |
| MRT | 26.0 | hr | Homo sapiens |
| T1/2 | 35.0 | hr | - |
| T1/2 | 26.0 | hr | Homo sapiens |
| Vd | 13.5 | L.kg-1 | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885861 | Rattus norvegicus | 1382 |
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 270 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 17870537 | 10.1016/j.bmc.2007.08.055 | Mus musculus | 17 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 17687333 | 10.1038/nature06038 | Unchecked | 8 |
| 1246052 | 10.1021/jm00223a010 | Mus musculus | 7 |
| 22757 | 10.1021/jm00199a014 | Mus musculus | 7 |
| 10447960 | 10.1021/jm9910369 | ADMET | 6 |
| 3806614 | 10.1021/jm00385a013 | Mus musculus | 5 |
| 6167716 | 10.1021/jm00135a006 | ADMET | 5 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 5 |
| - | 10.1007/s00044-009-9176-x | Mus musculus | 5 |
| 21474681 | 10.1124/dmd.111.038778 | Brain | 5 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 4 |
| 16168645 | 10.1016/j.bmcl.2005.08.040 | Mus musculus | 4 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
Data from ChEMBL 36 via Core Engine